Bradford Crown Court has heard that Shahid Malik, a former Member of Parliament, had “no controlling or managerial responsibility” within RT Diagnostics, a coronavirus testing firm facing allegations of fraudulent trading. The defense argues that although Malik profited from the company, there is no evidence to suggest he was involved in any wrongdoing related to its operations. This development comes during a trial centered on claims that RT Diagnostics provided unreliable and, at times, false COVID-19 test results, potentially endangering public health. The case, involving five defendants including Malik, centers on the firm’s activities between May and June 2021, a period when it generated £6.67 million in revenue.
The prosecution alleges that RT Diagnostics, established in Halifax, operated as a “testing laboratory” in name only, with tests reportedly “dumped in a room” and customers receiving fabricated negative results. The allegations raise serious questions about the integrity of COVID-19 testing during the pandemic and the potential for financial exploitation during a public health crisis. Shahid Malik, who served as a Justice Minister under Gordon Brown before losing his seat in 2010, denies charges of fraudulent trading, causing a public nuisance, and money laundering. The trial is examining the extent of his involvement and whether he knowingly participated in or benefited from any fraudulent activities.
Defense Claims Limited Role for Former MP
Jonathan Laidlaw KC, representing Malik, asserted to the jury that his client was a “non-executive director in the true sense of the word,” largely removed from the day-to-day running of RT Diagnostics. He emphasized that Malik’s role was primarily that of a shareholder and founder, alongside Faisal Shoukat, a former Calderdale councillor. Laidlaw argued that simply making a substantial profit from the company does not equate to guilt, stating, “The fact that Mr Malik made a great deal of money out of RT cannot possibly, or fairly, on its own be the basis of a guilty verdict.”
The defense contends that to find Malik guilty, the jury would need to conclude that he knew RT Diagnostics was either established as a fraudulent enterprise or that it subsequently descended into fraudulent practices. Laidlaw further stated that there is “absolutely no evidence” to suggest Malik was informed of any problems the company encountered during its initial trading period. He characterized the suggestion that the business was fraudulent from the outset as “absurd,” claiming that “all the evidence points in the opposite direction.”
Financial Transactions and Connections to Turkish Firm
The prosecution has highlighted that Malik received “just under” £1.5 million in dividends from RT Diagnostics by August 2021. However, the defense maintains that these payments were legitimate returns on his investment and do not inherently indicate fraudulent intent. The prosecution also alleges that Malik connected RT Diagnostics with a Turkish firm that supplied test kits not approved for leverage in the UK, and that he was involved in email communications regarding the company’s operations. The BBC reported that Malik, despite residing and working abroad for part of 2021, maintained a significant interest in the company’s affairs.
The court has heard that RT Diagnostics generated a “suspiciously low” number of positive results, raising concerns about the accuracy and reliability of its testing procedures. Prosecutors argue that the firm’s premises in Halifax were “shoddy and inadequate,” further questioning the validity of the tests conducted there. The trial is attempting to determine whether these shortcomings were the result of negligence or deliberate fraudulent activity.
The Broader Context of Pandemic Testing
The case against Shahid Malik and his co-defendants unfolds against a backdrop of widespread concerns about the quality and oversight of COVID-19 testing during the pandemic. Numerous private testing firms emerged during this period, often operating with limited regulatory scrutiny. The alleged failings of RT Diagnostics highlight the potential risks associated with relying on private companies to deliver essential public health services. The outcome of this trial could have implications for future regulations governing pandemic preparedness and the provision of testing services.
The trial continues at Bradford Crown Court, with the jury expected to deliberate on the evidence presented by both the prosecution and the defense. The allegations against RT Diagnostics and Shahid Malik represent a serious indictment of potential misconduct during a time of national crisis. The case underscores the importance of accountability and transparency in the delivery of public health services, particularly during emergencies. The court is expected to provide further updates as the trial progresses.
The next scheduled update from the court is anticipated following the conclusion of closing arguments, with a timeline for jury deliberation to be announced shortly thereafter. Individuals seeking further information on the case can follow reporting from reputable news organizations covering the proceedings.
If you have been affected by issues related to COVID-19 testing or believe you may have received inaccurate results, resources are available to help. You can find information and support from the National Health Service (NHS) at nhs.uk. For mental health support, the charity Mind offers a helpline and online resources at mind.org.uk. Please feel free to share your thoughts and experiences in the comments below.
Related reading
